163 related articles for article (PubMed ID: 23325341)
21. Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma.
Zhang HX; Jiang SS; Zhang XF; Zhou ZQ; Pan QZ; Chen CL; Zhao JJ; Tang Y; Xia JC; Weng DS
Oncotarget; 2015 Oct; 6(33):34800-17. PubMed ID: 26430962
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.
Wu X; Chen H; Gao Q; Bai J; Wang X; Zhou J; Qiu S; Xu Y; Shi Y; Wang X; Zhou J; Fan J
Mol Carcinog; 2014 Apr; 53(4):325-36. PubMed ID: 23169062
[TBL] [Abstract][Full Text] [Related]
23. Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma.
Zhang B; Dong LW; Tan YX; Zhang J; Pan YF; Yang C; Li MH; Ding ZW; Liu LJ; Jiang TY; Yang JH; Wang HY
Br J Cancer; 2013 Jul; 109(1):14-23. PubMed ID: 23764751
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine metabolic enzyme HPD is decreased and predicts unfavorable outcomes in hepatocellular carcinoma.
Yang X; Chen SL; Lin CS; Liu LL; Wang CH; Yun JP
Pathol Res Pract; 2020 Nov; 216(11):153153. PubMed ID: 32891822
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
26. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
27. KITENIN is associated with activation of AP-1 target genes via MAPK cascades signaling in human hepatocellular carcinoma progression.
Cho SB; Park YL; Park SJ; Park SY; Lee WS; Park CH; Choi SK; Heo YH; Koh YS; Cho CK; Chung IJ; Kim KK; Kim S; Joo YE
Oncol Res; 2011; 19(3-4):115-23. PubMed ID: 21473287
[TBL] [Abstract][Full Text] [Related]
28. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma.
Itoh S; Maeda T; Shimada M; Aishima S; Shirabe K; Tanaka S; Maehara Y
Clin Cancer Res; 2004 Apr; 10(8):2812-7. PubMed ID: 15102689
[TBL] [Abstract][Full Text] [Related]
29. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
30. Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma.
Denkert C; Schmitt WD; Berger S; Reles A; Pest S; Siegert A; Lichtenegger W; Dietel M; Hauptmann S
Int J Cancer; 2002 Dec; 102(5):507-13. PubMed ID: 12432554
[TBL] [Abstract][Full Text] [Related]
31. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
32. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of renal tumor antigen is associated with tumor invasion and poor prognosis of hepatocellular carcinoma.
Cha HJ; Kim J; Hong SM; Hong SJ; Park JH; Kim ES; Wang HJ; Choi YJ; Do IG; Joh JW; Kim DS; Choi KY
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S404-11. PubMed ID: 21717246
[TBL] [Abstract][Full Text] [Related]
34. MAP Kinase-Interacting Kinase 1 Promotes Proliferation and Invasion of Hepatocellular Carcinoma and Is an Unfavorable Prognostic Biomarker.
Wang X; Wang Y; Zhang Q; Zhuang H; Chen B
Med Sci Monit; 2018 Mar; 24():1759-1767. PubMed ID: 29576605
[TBL] [Abstract][Full Text] [Related]
35. Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients.
Ruan J; Zheng H; Rong X; Rong X; Zhang J; Fang W; Zhao P; Luo R
Mol Cancer; 2016 Feb; 15():17. PubMed ID: 26896959
[TBL] [Abstract][Full Text] [Related]
36. A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase.
Yu SJ; Won JK; Ryu HS; Choi WM; Cho H; Cho EJ; Lee JH; Kim YJ; Suh KS; Jang JJ; Kim CY; Lee HS; Yoon JH; Cho KH
Korean J Intern Med; 2014 Sep; 29(5):580-7. PubMed ID: 25228833
[TBL] [Abstract][Full Text] [Related]
37. Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
Wu S; Chen X; Hu C; Wang J; Shen Y; Zhong Z
Med Sci Monit; 2017 Dec; 23():5705-5713. PubMed ID: 29192136
[TBL] [Abstract][Full Text] [Related]
38. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.
Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL
Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295
[TBL] [Abstract][Full Text] [Related]
39. p53-induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection.
Wang XM; Yang LY; Guo L; Fan C; Wu F
Cancer; 2009 Oct; 115(19):4554-63. PubMed ID: 19551892
[TBL] [Abstract][Full Text] [Related]
40. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
